QGAI Quantum Genesis AI Corp.
Industrial Organic Chemicals · OTC · SEC CIK 1663038 · Fiscal year ends 07/31
Financial factors as of 2026-04-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-2,095.8%
TTM EPS YoY-1,995.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,381,839.5%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets751,378.0%
Debt / equity—
Current ratio0.00x
Interest coverage-3.78x
Cash quality & payout
Operating cash flow / net income0.02x
Accruals ratio-1,359,573.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-04-30 | 2026Q22026-01-31 | 2026Q12025-10-31 | 2025Q4*2025-07-31 | 2025Q32025-04-30 | 2025Q22025-01-31 | 2025Q12024-10-31 | 2024Q4*2024-07-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| SG&A expense | $5,966 | $19,411 | $16,102 | $1,764 | $11,453 | $3,335 | $1,577 | $1,550 |
| Operating income | -$19,083 | -$1,382 | -$39,196 | -$34,616 | -$60,453 | -$24,534 | -$60,934 | — |
| Interest expense | $5,829 | $2,403 | $10,672 | $6,061 | $5,310 | $5,272 | $4,589 | $4,033 |
| Pretax income | -$24,912 | -$4.33M | -$49,868 | -$38,177 | -$65,763 | -$29,806 | -$65,523 | -$41,228 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$24,912 | -$4.33M | -$49,868 | -$38,177 | -$65,763 | -$29,806 | -$65,523 | -$41,228 |
| EPS (basic) | — | — | — | — | 0.00 | — | — | — |
| EPS (diluted) | 0.00 | -0.12 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 35.33M | 35.33M | 38.96M | — | 35.33M | 35.33M | 34.74M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $59 | $59 | $184 | $584 | $584 | $1,754 | $5,068 | $0 |
| Current assets | $59 | $59 | $184 | $584 | $584 | — | — | $10,000 |
| Total assets | $59 | $59 | $184 | $584 | $584 | — | — | $10,000 |
| Current liabilities | $443,313 | $418,401 | $490,769 | $441,301 | $403,125 | — | — | $293,298 |
| Total liabilities | $443,313 | $418,401 | $490,769 | $441,301 | $403,125 | — | — | $293,298 |
| Shareholders' equity | -$443,254 | -$418,342 | -$490,585 | -$440,717 | -$402,541 | -$373,129 | -$343,323 | -$283,299 |
| Shares outstanding | 40.97M | 40.97M | 38.96M | 38.96M | 38.96M | — | — | 34.78M |
| Cash flow statement | ||||||||
| Operating cash flow | -$19,143 | -$23,897 | -$19,913 | -$8,631 | -$66,975 | -$14,518 | -$35,057 | -$13,450 |
| Financing cash flow | $19,143 | $23,772 | $19,513 | $8,631 | $65,805 | $11,204 | $40,125 | $13,450 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.